UNH director Baker receives 343 deferred stock units
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 343 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
Key Figures
Key Terms
deferred stock units financial
regular quarterly compensation financial
immediately vested financial
retained by the director until the director's completion of service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Charles D. Baker report at UNH?
Is the UNH Form 4 transaction a buy or a grant for Charles D. Baker?
What are deferred stock units in the UNH director compensation context?
Are Charles D. Baker’s deferred stock units at UNH immediately vested?
AI-generated analysis. How Rhea-AI works. Not financial advice.